An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

Assessment of Fc receptors and immune cells in breast cancer enables development of tailored engineering strategies for tumor-targeting monoclonal antibodies with enhanced immune-stimulating and anticancer attributes by combining glycoengineering and Fc mutations.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-10-23
DOI
https://doi.org/10.1158/0008-5472.can-24-3174
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

Jennifer Trendell, Daniel I. R. Spencer, Alicia M. Chenoweth, Shashi Jatiani et al.
Cancer Research
Monoclonal and Polyclonal Antibodies Research
article

An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

Jennifer Trendell, Daniel I. R. Spencer, Alicia M. Chenoweth, Shashi Jatiani, Gabriel Osborn, Amanda Gross, James M. McDonnell, Jitesh Chauhan, Jelmar Quist, Jack Cheeseman, Syed Aleem Haider, Anita Grigoriadis, Benjamina Esapa, Leonard Moise, Alexandra McCraw, Sophia N. Karagiannis, Rebecca Adams, Thomas Sénard, Richard A. Gardner, Anna M. Davies, Anthony Cheung, Kristina M. Ilieva, Sophia Tsoka, Judit Cserny, Pablo Romero-Clavijo, Roman Laddach, Sheeba Irshad, Katie Stoker, Andrew N.J. Tutt, Erin Suriawinata, Blanca Navarro‐Llinas, Melanie Grandits, Lev Brown, Astrid Clarke
article en

Abstract

Assessment of Fc receptors and immune cells in breast cancer enables development of tailored engineering strategies for tumor-targeting monoclonal antibodies with enhanced immune-stimulating and anticancer attributes by combining glycoengineering and Fc mutations.

Cancer ResearchVol. 85(22)
King's College London (GB), Breast Cancer Now (GB), London Cancer (GB), Culham Science Centre (GB), London Institute for Mathematical Sciences (GB), Scientific Systems (United States) (US)
Openalex Percentile: Top 55%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.